|
(Health-NewsWire.Net, October 13, 2021 )
Market Overview
Adenovirus is one of the DNA viruses that are considered to be a major cause of febrile illness, primarily among children. Individuals and Infants with weak immune systems, cardiac disease, or chronic respiratory problems are at higher risk of developing adenovirus infection.
However, most infections are not severe. Adenovirus is a communicable infection, as it is an air-borne disease and can spread from an infected person to others by coughing and sneezing and close contact, such as shaking or touching hands.
View full report: https://bit.ly/3v4Piwq
Market Dynamics
The rapid adenovirus testing market growth is driven by the increasing advancements in the diagnosis of acute respiratory infections of adenovirus, the rising demand from SMEs and various industry verticals, macro-economic growth, and growth in research and development of technologies are the prime factors of the market.
Increasing aid in the diagnosis and treating of adenovirus is expected to drive the growth in the forecast period
Adenoviruses are associated with various non-specific manifestations and clinical syndromes. Thus, diagnosis based upon clinical criteria alone is challenging. Diagnosis is most accurate when the infection shows outbreak symptoms or individuals show serious disease manifestations.
Validation of adenovirus infection is essential for identifying the most appropriate treatment to establish a prognosis and initiate infection control measures using correct antiviral agents, thus making the diagnosis of these viruses a necessary procedure.
The rapid detection and quantitation of adenovirus DNA, especially by a sensitive PCR technique, is expected to aid in diagnosing and treating adenovirus infections, particularly in immunocompromised patients. This, in turn, is expected to drive the growth of the rapid adenovirus testing market.
Market Segmentation:
By Assay
• Lateral Flow Immunochromatographic Assay
• Immunogold Assay
• PCR-Enzyme Hybridization Assay
By Diagnosis
• Polymerase Chain Reaction (PCR)
• Antigen Detection
• Virus Isolation
• Monoclonal Antibodies
By End-User
• Hospitals
• Diagnostic Laboratories
• Clinics
Download free sample: https://bit.ly/3BBJahB
Geographical Analysis
North America region holds the largest market share of the global rapid adenovirus testing market
North America is expected to gain significant traction due to growing public health concerns regarding various infectious diseases such as pneumonia associated with adenovirus infection.
For instance, in 2014, the eighth cause of mortality in the U.S. was influenza and pneumonia together, as reported by the National Centre for Health Statistics. Manufacturers offer a variety of immunoassays for the detection of adenovirus antigens. The SD BIOLINE Rota / Adeno Ag test is one of Abbott's immunochromatographic analyses that qualitatively detects the presence of rotavirus or adenovirus antigens in human feces specimens.
For instance, in 2017, Abbott worked with UCSF (University of California, San Francisco) to detect new viruses and develop traits and diagnostic tools to resolve potential health threats caused by adenovirus. Herb and Marion Sandler's seed funding to the collaboration supported the development of the ViroChip.
Supplier is also focused on improving the quality of analysis by performing surveillance projects in various hospitals, which are expected to create profitable growth opportunities in this market.
Competitive Landscape
The global rapid adenovirus testing market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include Biopanda Reagents Ltd, CTK Biotech Inc, Creative Diagnostics, Biomérieux India Private Limited, Accuquik, SA Scientific, F. Hoffmann-La Roche Ltd, Diasorin S.P.A, Bio-Rad Laboratories Inc., QIAGEN, Intec Products Inc.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, QIAGEN's NeuMo Dx ™ HAdV Quant Assay got CEIVD certificate on 9 July 2021 for automated testing for the detection of human adenovirus infection.
Related Topic's
Tissue Dissociation Market, Gene Panel Market, Biobetters Market, Oncolytic Virus Therapy Market, Monoclonal Antibody Therapeutics Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
